Trxade Group Inc. MEDS Archives - Page 4 of 9

ThursdayAug 13, 2020 10:33 am

Trxade Group, Inc. (NASDAQ: MEDS) to Present at LD Micro’s LD 500 Virtual Conference

The exclusively online LD 500 event is expected to gather more than 300 companies and 20,000 attendees in early September Trxade reported record revenue in Q2 2020 and expects a strong second half of the year If telemedicine services maintain popularity, market analysts project a seven-fold increase for the industry by 2025 Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, will present at the virtual LD 500 in early September to an expected online audience of more than 20,000.The event is organized by LD Micro, an independent resource to the microcap world, which started off as…

TuesdayAug 11, 2020 11:22 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Launches First-of-Its-Kind B2B Platform

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform,has unveiled Bonum+, a business-to-business platform that bundles telehealth, a COVID-19 risk assessment tool and a Personal Protective Equipment (“PPE”) purchasing tool together. Available through MEDS subsidiary Bonum Health, the platform, which is the first of its kind, will be available through a secure mobile dashboard and is designed to ease pressure on employees who are mandated to report relevant health issues daily. Bonum+ centralizes communication and contact tracing to deliver risk scores. “I am proud of the entire team at Bonum Health, a Trxade Group company, for their efforts…

FridayAug 07, 2020 10:37 am

Trxade Group, Inc. (NASDAQ: MEDS) Continues to Report Revenue Successes Despite Pandemic’s Economic Ravages

Trxade Group provides a digitalized supply stream for pharmaceutical and health care services as part of its founding focus on empowering small, independent pharmacies that historically have struggled to compete against large corporate chains The company reported second quarter results July 27 that showed its revenues had grown 244 percent to a record $6.6 million in year-over-year quarterly results, triple the amount garnered during the first quarter of the year The global COVID-19 pandemic caught world markets by surprise during the spring, but Trxade’s emphasis on telemedicine and other online-accessible services positioned it as a visionary company well able to…

WednesdayAug 05, 2020 2:03 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Keeps Telehealth Patients in-the-Know with Timely Educational Resources

Trxade Group (NASDAQ: MEDS) recently expanded Bonum Health, its patient-empowerment telehealth platform, to add access to educational resources to assist its users with better understanding and tools to direct their care management. The secure, privacy-enabled platform is particularly timely amid the COVID-19 pandemic and increased need for remote healthcare access for patients around the globe. An article discussing expansion of the app to now provide even more power to patients reads, “Trxade Group’s wholly owned mobile telehealth application will now link to the Merck Manual, a standard reference guide for physicians since 1899, according to the announcement. The company’s intent…

WednesdayJul 29, 2020 11:45 am

Trxade Group, Inc. (NASDAQ: MEDS) Reports Record 244% YoY Revenue Growth in Q2 2020

As the spread of the novel coronavirus unexpectedly reached pandemic proportions, Trxade Group stepped in to help patients and providers continue to access resources and PPE products through a virtual environment that is safe from contagion If telemedicine services maintain popularity with patients and insurance providers continue to be responsive to reimbursing telehealth claims, market analysts project a seven-fold increase for the industry by 2025 Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, reported its financial results for the second quarter ended June 30, 2020. According to the report, revenues for the second quarter of 2020…

TuesdayJul 28, 2020 10:01 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Record Financial Results for Q2 2020

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, on Monday provided its financial results for the second quarter ended June 30, 2020. Among the highlights, Trxade reported record revenues and an increase in growth profit. “The second quarter financial results, which showcased a 244% increase in revenues to a record $6.6 million and 72% increase in gross profit to $2.0 million,” Suren Ajjarapu, chairman and CEO of Trxade Group, stated in the news release. “This growth was driven by Personal Protective Equipment sales, such as N95 masks and sanitizer products through our Integra Pharma unit. As…

ThursdayJul 23, 2020 11:12 am

Trxade Group Inc. (NASDAQ: MEDS) To Present 2nd Quarter Financial Report Amid Pandemic-driven Growth in Telehealth Services

Pharmaceutical and health care services company Trxade Group Inc. is enjoying growing attention as it continues to roll out remote-access medical solutions that are suited to the ongoing COVID-19 pandemic and the need to prevent virus transmission The company will announce its second quarter financial report July 27 following the close of markets that day Telehealth claims to private insurers have grown by 4,347 percent year-over-year during the past few months in which the pandemic has swept the planet Trxade Group’s introduction of the Bonum Health Hub and online pharmaceutical ordering and delivery services has driven the company’s customer responsiveness…

MondayJul 20, 2020 1:38 pm

QualityStocksNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Corporate Presentation Highlights Milestones, Growing Popularity of Platform

Trxade Group (NASDAQ: MEDS) recently released a corporate presentation that highlights the company’s major milestones, increased revenues and earnings, and the growing popularity of its pharmaceutical platform (http://ibn.fm/4F16k). An article that discusses the presentation, as well as the company’s achievements as they stand today and since its inception, reads, “Founded in 2010 by MEDS CEO Suren Ajjarapu along with MEDS COO and President Prashant Patel, the Trxade Group spent its first three years working on the technology that would underlie its innovative pharmaceutical platform. Dedicated and passionate, Ajjarapu and Patel bootstrapped early development with some $5.5M of their own funds.…

WednesdayJul 15, 2020 1:31 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Report Q2 2020 Financial Results, Host Conference Call

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced plans to release its financial results for the second quarter ended June 30, 2020, after market close on Monday, July 27, 2020. According to the update, Trxade Group management will host a conference call at 5:00 p.m. Eastern Time, also on July 27, to discuss the company’s second quarter financial results and conclude with a Q&A from participants. Interested parties may participate by dialing 1-877-425-9470 (U.S.) or 1-201-389-0878 (International) and entering Conference ID: 13707025. To view the full press release, visit http://ibn.fm/Hzxg7 About Trxade Group, Inc.…

WednesdayJul 15, 2020 11:48 am

Trxade Group Inc. (NASDAQ: MEDS) Pharmaceutical Platform May Save America’s Independent Pharmacies

The need for efficient drug procurement and delivery has never been more in demand Trxade Group’s unmatched supply chain trading platform represents a unique portal to speeding up drug distribution Such efficiencies are key to improving margins and keeping America’s independent pharmacies alive Not in recent memory have medical services and associated support personnel been viewed as more vital to the nation. Just as indispensable, but not as visible, are the supply chain channels through which medical supplies flow, for doctors without medicines may be so handicapped as to be useless. So too would be pharmacies where the bulk of…

Site Search

Company Search

Tag: Trxade Group Inc. MEDS